Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Board member Herzberg sells Vidac Pharma shares: 12,500 units at €0.43

On 01.09.2026, board member Dr. Max Herzberg reported the sale of 12,500 Vidac Pharma shares at €0.43 each; the transaction was received by BaFin on 03.09.2026. Previously, Herzberg had already disposed of 10,000 shares at €0.42. The Vidac Pharma share was unchanged at €0.41 in FSE trading; market capitalization is around €20.91 million with 51,625,060 freely tradable shares. » Plus sur finanzen.net
Vidac Pharma: board member Herzberg sells 10,000 shares

Board member Dr. Max Herzberg reduced his position on 01.09.2026 by 10,000 Vidac Pharma shares at EUR 0.42; the transaction was officially reported on 03.09.2026. The stock traded that day at about EUR 0.41 and thus remained almost unchanged. Market capitalization is around EUR 20.91 million; 51,625,060 shares are in the free float. » Plus sur finanzen.net
Vidac Pharma: board member Herzberg sells shares and reduces stake

Board member Herzberg, Dr. Max, sold a total of 20,000 Vidac Pharma shares on 25 Aug 2026 at an offer price of €0.44 (transaction officially recorded on 28 Aug 2026). Previously, on 24 Aug 2026 a personal transaction of 11,000 shares at €0.45 each was reported. The stock subsequently showed no major swings and traded at times around €0.41–€0.42. Vidac Pharma’s market capitalization is about €21.53 million. » Plus sur finanzen.net